Evidence map›Paper›PMID 34927666›Full record

ArticleBioinformatics (Oxford, England)2022

Identifying cancer pathway dysregulations using differential causal effects.

Kim Philipp Jablonski, Martin Pirkl, Domagoj Ćevid, Peter Bühlmann, Niko Beerenwinkel

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. CEACAM7 Expression and DNA Methylation: Prognostic Biomarkers for Lung Adenocarcinoma in African Americans.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Article
  2. Article
  3. Molecular principles underlying aggressive cancers.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kim Philipp JablonskiDepartment of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.ORCID 0000-0002-4166-4343
Martin PirklDepartment of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.ORCID 0000-0002-6986-0813
Domagoj ĆevidSeminar for Statistics, ETH Zürich, 8092 Zürich, Switzerland.
Peter BühlmannSeminar for Statistics, ETH Zürich, 8092 Zürich, Switzerland.
Niko BeerenwinkelDepartment of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.ORCID 0000-0002-0573-6119

Funding

ERC Synergy Grant 609883European Research Council (ERC) 786461Swiss Initiative in Systems Biology RTD 2013/152Swiss National Science FoundationSystemsX.chTargetInfectX-Multi-Pronged Perturbation of Pathogen Infection in Human Cells
6 · The paper itself

Abstract

motivationSignaling pathways control cellular behavior. Dysregulated pathways, for example, due to mutations that cause genes and proteins to be expressed abnormally, can lead to diseases, such as cancer.

resultsWe introduce a novel computational approach, called Differential Causal Effects (dce), which compares normal to cancerous cells using the statistical framework of causality. The method allows to detect individual edges in a signaling pathway that are dysregulated in cancer cells, while accounting for confounding. Hence, technical artifacts have less influence on the results and dce is more likely to detect the true biological signals. We extend the approach to handle unobserved dense confounding, where each latent variable, such as, for example, batch effects or cell cycle states, affects many covariates. We show that dce outperforms competing methods on synthetic datasets and on CRISPR knockout screens. We validate its latent confounding adjustment properties on a GTEx (Genotype-Tissue Expression) dataset. Finally, in an exploratory analysis on breast cancer data from TCGA (The Cancer Genome Atlas), we recover known and discover new genes involved in breast cancer progression. AVAILABILITY AND IMPLEMENTATION: The method dce is freely available as an R package on Bioconductor (https://bioconductor.org/packages/release/bioc/html/dce.html) as well as on https://github.com/cbg-ethz/dce. The GitHub repository also contains the Snakemake workflows needed to reproduce all results presented here. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Breast NeoplasmsSoftwareFemaleGenomeHumansSignal Transduction

Identifiers

PMID34927666
PMCPMC8896597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.